Literature DB >> 8413301

Biphasic ordered induction of heme synthesis in differentiating murine erythroleukemia cells: role of erythroid 5-aminolevulinate synthase.

H Lake-Bullock1, H A Dailey.   

Abstract

During dimethyl sulfoxide (DMSO)-stimulated differentiation of murine erythroleukemia (MEL) cells, one of the early events is the induction of the heme biosynthetic pathway. While recent reports have clearly demonstrated that GATA-1 is involved in the induction of erythroid cell-specific forms of 5-aminolevulinate synthase (ALAS-2) and porphobilinogen (PBG) deaminase and that cellular iron status plays a regulatory role for ALAS-2, little is known about regulation of the remainder of the pathway. In the current study, we have made use of a stable MEL cell mutant (MEAN-1) in which ALAS-2 enzyme activity is not induced by DMSO, hexamethylene bisacetamide (HMBA), or butyric acid. In this cell line, addition of 2% DMSO to growing cultures results in the normal induction of PBG deaminase and coproporphyrinogen oxidase but not in the induction of the terminal two enzymes, protoporphyrinogen oxidase and ferrochelatase. These DMSO-treated cells did not produce mRNA for beta-globin and do not terminally differentiate. In addition, the cellular level of ALAS activity declines rapidly after addition of DMSO, indicating that ALAS-1 must turn over rapidly at this time. Addition of 75 microM hemin alone to the cultures did not induce cells to terminally differentiate or induce any of the pathway enzymes. However, the simultaneous addition of 2% DMSO and 75 microM hemin caused the cells to carry out a normal program of terminal erythroid differentiation, including the induction of ferrochelatase and beta-globin. These data suggest that induction of the entire heme biosynthetic pathway is biphasic in nature and that induction of the terminal enzymes may be mediated by the end product of the pathway, heme. We have introduced mouse ALAS-2 cDNA into the ALAS-2 mutant cell line (MEAN-1) under the control of the mouse metallothionein promoter (MEAN-RA). When Cd and Zn are added to cultures of MEAN-RA in the absence of DMSO, ALAS-2 is induced but erythroid differentiation does not occur and cells continue to grow normally. In the presence of metallothionein inducers and DMSO, the MEAN-RA cells induce in a fashion similar to that found with the wild-type 270 MEL cells. Induction of the activities of ALAS, PBG deaminase, coproporphyrinogen oxidase, and ferrochelatase occurs. In cultures of MEAN-RA where ALAS-2 had been induced with Cd plus Zn 24 h prior to DMSO addition, onset of heme synthesis occurs more rapidly than when DMSO and Cd plus Zn are added simultaneously. This study reveals that induction of ALAS-2 alone is not sufficient to induce terminal differentiation of the MEAN-RA cells, and it does not appear that ALAS-2 alone is the rate-limiting enzyme of the heme biosynthetic pathway during MEL cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413301      PMCID: PMC364773          DOI: 10.1128/mcb.13.11.7122-7132.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Erythroid 5-aminolevulinate synthase is located on the X chromosome.

Authors:  T C Cox; M J Bawden; N G Abraham; S S Bottomley; B K May; E Baker; L Z Chen; G R Sutherland
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

2.  Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome.

Authors:  D F Bishop; A S Henderson; K H Astrin
Journal:  Genomics       Date:  1990-06       Impact factor: 5.736

3.  Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.

Authors:  P D Cotter; M Baumann; D F Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Regulation by heme of mitochondrial protein transport through a conserved amino acid motif.

Authors:  J T Lathrop; M P Timko
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

Review 5.  Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.

Authors:  B K May; C R Bhasker; M J Bawden; T C Cox
Journal:  Mol Biol Med       Date:  1990-10

6.  Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation. Possible role for coproporphyrinogen oxidase.

Authors:  L H Conder; S I Woodard; H A Dailey
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

7.  Erythroleukemia differentiation. Distinctive responses of the erythroid-specific and the nonspecific delta-aminolevulinate synthase mRNA.

Authors:  H Fujita; M Yamamoto; T Yamagami; N Hayashi; S Sassa
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

8.  Expression of mammalian 5-aminolevulinate synthase in Escherichia coli. Overproduction, purification, and characterization.

Authors:  G C Ferreira; H A Dailey
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA.

Authors:  T Dandekar; R Stripecke; N K Gray; B Goossen; A Constable; H E Johansson; M W Hentze
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA.

Authors:  T C Cox; M J Bawden; A Martin; B K May
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  10 in total

Review 1.  One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans.

Authors:  Iqbal Hamza; Harry A Dailey
Journal:  Biochim Biophys Acta       Date:  2012-05-08

2.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

3.  Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins.

Authors:  K Itoh; K Igarashi; N Hayashi; M Nishizawa; M Yamamoto
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  A Novel Role for Progesterone Receptor Membrane Component 1 (PGRMC1): A Partner and Regulator of Ferrochelatase.

Authors:  Robert B Piel; Mesafint T Shiferaw; Ajay A Vashisht; Jason R Marcero; Jeremy L Praissman; John D Phillips; James A Wohlschlegel; Amy E Medlock
Journal:  Biochemistry       Date:  2016-09-09       Impact factor: 3.162

5.  Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.

Authors:  Sriram Krishnamoorthy; Betty Pace; Dipti Gupta; Sarah Sturtevant; Biaoru Li; Levi Makala; Julia Brittain; Nancy Moore; Benjamin F Vieira; Timothy Thullen; Ivan Stone; Huo Li; William E Hobbs; David R Light
Journal:  JCI Insight       Date:  2017-10-19

6.  The immunometabolite itaconate inhibits heme synthesis and remodels cellular metabolism in erythroid precursors.

Authors:  Jason R Marcero; James E Cox; Hector A Bergonia; Amy E Medlock; John D Phillips; Harry A Dailey
Journal:  Blood Adv       Date:  2021-12-14

7.  Posttranslational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery.

Authors:  Daniel R Crooks; Manik C Ghosh; Ronald G Haller; Wing-Hang Tong; Tracey A Rouault
Journal:  Blood       Date:  2009-11-25       Impact factor: 22.113

8.  Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation.

Authors:  K Igarashi; K Itoh; N Hayashi; M Nishizawa; M Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Glutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis.

Authors:  Joseph S Burch; Jason R Marcero; John Alan Maschek; James E Cox; Laurie K Jackson; Amy E Medlock; John D Phillips; Harry A Dailey
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113

10.  Identification of the Mitochondrial Heme Metabolism Complex.

Authors:  Amy E Medlock; Mesafint T Shiferaw; Jason R Marcero; Ajay A Vashisht; James A Wohlschlegel; John D Phillips; Harry A Dailey
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.